Stiffness Measurement of Liver Tumors and Visceral Parenchyma

• Conditions: Hepatocellular Carcinoma

• Registration Number: NCT01343212
• Lead Sponsor: China Medical University Hospital

Brief Summary

The investigators are measuring hepatocellular carcinoma(HCC)stiffness using Acoustic Radiation Force Impulse (ARFI) technique to enhance the diagnostic accuracy for HCC stratifications and treatment efficacy.

Detailed Description

Regression modelings as well as validity testings including cut-off identification will be acquired by performing both qualitative and quantitative measurements of HCC using reference diagnostic modalities e.g. pathology grading, dynamic CT scanning, etc.

Study Timeline

• Study Start: 2011-03
• Study First Submitted: 2011-04-26
• Study First Submitted QC: 2011-04-27
• Study First Posted: 2011-04-28
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-17
• Last Update Posted: 2011-05-18
• Primary Completion: 2012-03
• Study Completion: 2012-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

with HCC

Exclusion Criteria

• subjects with liver cancer other than HCC
• subjects with treated HCC
• post major abdominal surgery
• contraindications to liver tumor biopsy
• contraindications to local percutaneous treatment of liver tumors
• ARFI measurement low quality

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital; 🇨🇳 Taichung, Taiwan